Explore

Trendline Trendline
Cocrystal Pharma Appoints James Sapirstein as CEO to Lead Antiviral Development

Cocrystal Pharma Appoints James Sapirstein as CEO to Lead Antiviral Development

Cocrystal Pharma Appoints James Sapirstein as CEO to Lead Antiviral Development
Trendline Trendline
Pradip Patiath Joins Securian Financial Board of Directors

Pradip Patiath Joins Securian Financial Board of Directors

Pradip Patiath Joins Securian Financial Board of Directors
Trendline Trendline
hVIVO Partners with Decoy Therapeutics for Antiviral Development Consultancy

hVIVO Partners with Decoy Therapeutics for Antiviral Development Consultancy

hVIVO Partners with Decoy Therapeutics for Antiviral Development Consultancy
Trendline Trendline
Moderna's mRNA Melanoma Vaccine Shows Promising 5-Year Survival Results

Moderna's mRNA Melanoma Vaccine Shows Promising 5-Year Survival Results

Moderna's mRNA Melanoma Vaccine Shows Promising 5-Year Survival Results
Trendline Trendline
Pradip Patiath Joins Securian Financial Board, Bringing Expertise in Financial Services and Technology

Pradip Patiath Joins Securian Financial Board, Bringing Expertise in Financial Services and Technology

Pradip Patiath Joins Securian Financial Board, Bringing Expertise in Financial Services and Technology
Trendline Trendline
Cocrystal Pharma Appoints James Sapirstein as CEO to Drive Antiviral Development

Cocrystal Pharma Appoints James Sapirstein as CEO to Drive Antiviral Development

Cocrystal Pharma Appoints James Sapirstein as CEO to Drive Antiviral Development
Trendline Trendline
ENYO Pharma Appoints Jeff George as Chairman to Lead Phase 3 Development

ENYO Pharma Appoints Jeff George as Chairman to Lead Phase 3 Development

ENYO Pharma Appoints Jeff George as Chairman to Lead Phase 3 Development
Trendline Trendline
Ardena Appoints Ariane de Ganck as Chief Scientific Officer to Enhance Drug Development

Ardena Appoints Ariane de Ganck as Chief Scientific Officer to Enhance Drug Development

Ardena Appoints Ariane de Ganck as Chief Scientific Officer to Enhance Drug Development
Trendline Trendline
hVIVO Partners with Decoy Therapeutics for Antiviral Development

hVIVO Partners with Decoy Therapeutics for Antiviral Development

hVIVO Partners with Decoy Therapeutics for Antiviral Development
Trendline Trendline
Decoy Therapeutics and hVIVO Collaborate to Advance Antiviral Drug Development

Decoy Therapeutics and hVIVO Collaborate to Advance Antiviral Drug Development

Decoy Therapeutics and hVIVO Collaborate to Advance Antiviral Drug Development
Trendline Trendline
hVIVO Signs Consultancy Deal with Decoy Therapeutics for Antiviral Development

hVIVO Signs Consultancy Deal with Decoy Therapeutics for Antiviral Development

hVIVO Signs Consultancy Deal with Decoy Therapeutics for Antiviral Development
Trendline Trendline
Decoy Therapeutics Partners with hVIVO to Advance Antiviral Candidate into Clinical Trials

Decoy Therapeutics Partners with hVIVO to Advance Antiviral Candidate into Clinical Trials

Decoy Therapeutics Partners with hVIVO to Advance Antiviral Candidate into Clinical Trials